0001209191-23-012123.txt : 20230223 0001209191-23-012123.hdr.sgml : 20230223 20230223145126 ACCESSION NUMBER: 0001209191-23-012123 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230210 FILED AS OF DATE: 20230223 DATE AS OF CHANGE: 20230223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HU ANGELA CENTRAL INDEX KEY: 0001966685 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37347 FILM NUMBER: 23659053 MAIL ADDRESS: STREET 1: 5217 WINNEBAGO LN CITY: AUSTIN STATE: TX ZIP: 78744 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5217 WINNEBAGO LANE CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2900 MAIL ADDRESS: STREET 1: 5217 WINNEBAGO LANE CITY: AUSTIN STATE: TX ZIP: 78744 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-02-10 0 0001626878 XBiotech Inc. XBIT 0001966685 HU ANGELA 5217 WINNEBAGO LN AUSTIN TX 78744 0 1 0 0 Principle Financial Officer Common Stock 25500 D Employee Stock Option (right to buy) 19.00 2016-04-01 2025-04-01 Common Stock 4500 D Employee Stock Option (right to buy) 5.26 2020-01-04 2029-01-03 Common Stock 5000 D Employee Stock Option (right to buy) 10.36 2020-11-06 2029-11-05 Common Stock 10000 D Employee Stock Option (right to buy) 12.67 2022-11-19 2031-11-18 Common Stock 10000 D Employee Stock Option (right to buy) 3.84 2023-08-10 2033-02-09 Common Stock 30000 D On April 1, 2015 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in four equal portions in four years commencing as of April 1, 2016, with an expiry of ten years from the Grant Date. On January 4, 2019 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions in two years commencing as of January 4, 2020, with an expiry of ten years from the Grant Date. On November 6, 2019 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions in two years commencing as of November 6, 2020, with an expiry of ten years from the Grant Date. On November 19, 2021 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions in two years commencing as of November 19, 2022, with an expiry of ten years from the Grant Date. On February 10, 2023 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in four equal portions in two years commencing as of August 10, 2023, with an expiry of ten years from the Grant Date. /s/ Angela Hu 2023-02-23